Bio Saga Blog - A Chronicle of Life Sciences & Informatics

Is organizing "4 Days Workshop on In silico Drug Discovery (21st-24th Jan2016)” Know about drug discovery & optimize your research work CADD is a rapidly developing branch of chemistry. In the coming days the students who have studied CADD will be required not only in India but  across the globe for advanced research and new discovery.The requirement of trained manpower from the discipline such as Chemistry, Biology and Microbiology is the fuel for the growth of CADD.  Application of CADD is in areas like Agrochemical, pharmaceutical and biotechnological industries, Computational chemistry and library design groups, Chemical software companies, Database developers, Chemical publishers, In-silico Drug Discovery, Toxicity predictions, ADME prediction of Molecules, Chemicals Vendors , R&D, etc. On completion of this workshop you will be expertise in: ü        Analyzing chemical fingerprint ü     ...

Established in 2011, Bionivid Technology, located in the happening start-up hub of Bangalore, is a genomics and informatics start-up, jointly cofounded by Mr Madavan Vasudevan, Mr Rohit Nandan Shukla and Mr Hitesh Goswami. Mr Madavan is a qualified microbiologist-turned-bioinformatician; His partner Mr Rohit is also a qualified bioinformatician and a certified programmer; and Mr Hitesh is a neurobiologist with a fine business acumen. All three of them make a perfect ingredient for raising a hot bioinformatics start-up. - See more at: http://www.biospectrumindia.com/biospecindia/features/221910/hot-start-ups-believe-leap-faith#.dpuf

We are bringing out a special program, due to huge no of  enquirers  and considering a special demand by all to conduct a special batch of training on following topic Area of training/Internship Protein modeling & Drug discovery Start date - 15 th  July Emerging trend in healthcare and drug development is being appreciated and this success is being sound after a long dedicated research work on drug discovery, modeling & simulation. If you are giving a thought on finding novel drug, new molecules, we are here to help you. RASA has been very keen to give your research work a novel touch, providing few advanced skill set to you within a framed syllabus designed for you.     APPLY HERE   What will you learn? ·          Give inside how receptor binds to ligand. ·          Help to find ligand activity. ·   ...

At the Bio-IT World Conference last week, Intel unveiled a new website, dubbed Optimized Code, that offers access to versions of several popular open-source bioinformatics analysis tools that the company has optimized to run on Intel Xeon processors, with the aim of generating results faster and more efficiently than standard iterations of these solutions. The first set of applications that the company has released specifically for genomic analysis include optimized versions of  the Broad Institute's Genome Analysis Toolkit ; Blast algorithms for nucleotide- and protein-based sequence searching; BWA-ALN , software for mapping low-divergent sequences to a reference genome; and MPI-HMMER , protein sequence analysis software. The company has also released optimized code for AMBER and NAMD, both of which are used for simulating the molecular dynamics of biomolecular systems. The Intel website provides performance numbers for each of the optimized codes as well as directions for h...

PerkinElmer announced yesterday that it has signed an agreement with Waters to offer solutions combing the firm's chromatography instruments and software. Under the agreement, PerkinElmer's liquid and gas chromatography portfolio will be standardized on Waters' Empower Software, which is used to manage multi-vendor chromatography data, simplifying data collection, processing, and reporting.  PerkinElmer said this standardization will enable its customers to simplify their workflows by unifying their chromatography data onto one platform. It also said that it anticipates the alliance with Waters will lead to new product launches in the environmental, industrial, and applied markets. Financial and other terms of the agreement were not disclosed.